FDA Settles Safety Report Requirements for Combination Products after Seven Years

Drug Industry Daily
The type of postmarket safety report required for a combination medical product will be based on whether the product was approved through a drug, biologic, or device application, according to the FDA’s final rule published today.

To View This Article:


Subscribe To Drug Industry Daily